N276-12

N/A

Report date: 2025/01/14 17:24:56
NME

Base Information

Drug NameN276-12
Drug Alias Name2-phenyl-3-(N-methyl-3-piperidyl)carbonylammomiinomemyl-5,6,7,8-tetrahydVoimidazo[2,1-b]benzothiazoleN276-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Renal CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyushu UniversityNikken Chemicals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNikken Chemicals Co LtdKyushu University
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal CellNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A